Castleview Partners’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-96
Closed -$12.6K 359
2024
Q4
$12.6K Sell
96
-2
-2% -$285 0.01% 548
2024
Q3
$12.7K Sell
98
-1
-1% -$123 0.01% 519
2024
Q2
$10.3K Sell
99
-3
-3% -$337 0.01% 518
2024
Q1
$13.6K Hold
102
0.01% 513
2023
Q4
$13.8K Sell
102
-1,379
-93% -$159K 0.01% 484
2023
Q3
$198K Sell
1,481
-13
-0.9% -$2.14K 0.18% 115
2023
Q2
$272K Buy
1,494
+56
+4% +$11.3K 0.25% 88
2023
Q1
$326K Sell
1,438
-76
-5% -$15.6K 0.29% 84
2022
Q4
$298K Buy
1,514
+221
+17% +$45.8K 0.29% 83
2022
Q3
$240K Sell
1,293
-19,959
-94% -$3.95M 0.23% 95
2022
Q2
$429K Buy
21,252
+20,618
+3,252% +$5.27M 0.34% 67
2022
Q1
$215K Sell
634
-478,845
-100% -$162M 0.13% 152
2021
Q4
$1.23K Buy
+479,479
New +$182M 0.01% 362
2021
Q2
$476K Buy
+1,034
New +$416K 0.21% 102

Other funds holding ILMN

Castleview Partners's ILMN Position: Q1 2025 in Review

Castleview Partners sold out of Illumina (ILMN) in Q1 2025, closing a stake of 96 shares — an estimated $12.6K sold.

Castleview Partners first reported a position in ILMN in Q2 2021 and held it in 14 quarters. The position peaked at $476K in Q2 2021. 721 funds tracked by Wall St. Rank hold ILMN as of Q1 2025.

  • Castleview Partners reported no remaining Illumina position as of Q1 2025 after selling out during the quarter.
  • Castleview Partners sold 96 Illumina shares in Q1 2025, an estimated $12.6K.
  • Castleview Partners first reported a position in Illumina in Q2 2021 and held it in 14 quarters.
  • Castleview Partners's Illumina position peaked at $476K in Q2 2021.
  • 721 funds tracked by Wall St. Rank held Illumina as of Q1 2025.

Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.